- $1.48bn
- $1.86bn
- $316.30m
- 88
- 44
- 79
- 82
Annual income statement for Meridianlink, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 199 | 268 | 288 | 304 | 316 |
| Cost of Revenue | |||||
| Gross Profit | 141 | 178 | 182 | 195 | 208 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 154 | 240 | 259 | 288 | 312 |
| Operating Profit | 45.6 | 27.7 | 28.6 | 15.5 | 4.64 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 10.9 | -4.86 | 5.42 | -18.6 | -28.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 9.15 | -10 | 1.29 | -42.5 | -29.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 9.15 | -10 | 1.29 | -42.5 | -29.8 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -25.3 | -30.9 | 1.29 | -42.5 | -29.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.14 | -0.293 | 0.055 | -0.5 | -0.317 |
| Dividends per Share |